$NOVO B #Novo Nordisk A/S B Novo Nordisk - Is ADA a done deal before it has even started?: What we can learn from the released ADA data abstracts Pfizer a pleasant surprise, best GLP-1 is still semaglutide No change to our fundamental LT… https://t.co/dZ55AVrn3k #equity #stocks https://t.co/UTMyxFB8Fi